List of human disease case fatality rates

Last updated

Human infectious diseases may be characterized by their case fatality rate (CFR), the proportion of people diagnosed with a disease who die from it ( cf. mortality rate). It should not be confused with the infection fatality rate (IFR), the estimated proportion of people infected by a disease-causing agent, including asymptomatic and undiagnosed infections, who die from the disease. IFR cannot be higher than the CFR and is often much lower, but is also much harder to calculate. This data is based on optimally treated patients and exclude isolated cases or minor outbreaks, unless otherwise indicated.

DiseaseTypeTreatment stage[ clarification needed ] CFR NotesReference(s)
Transmissible spongiform encephalopathy Prion No treatment and no cure [1] 100% [2] Includes Creutzfeldt–Jakob disease and all its variants, fatal insomnia, kuru, Gerstmann–Sträussler–Scheinker syndrome, Variably protease-sensitive prionopathy and others. [3] No cases of survival, invariably fatal.
Rabies ViralUnvaccinated>99% [4] Preventable with vaccine and PEP but once symptoms manifest, there is no cure and the CFR is greater than 99%. 4 known people who survived were simply vaccinated too late, [5] after symptoms started; more recently, at least 3 individuals have survived after being placed in a medically induced coma, however this protocol has since been disputed. [6] 29 known cases of survival
Plague, pneumonic BacterialUnvaccinated and untreated≈100% [7] : 58 
African trypanosomiasis Parasitic (protozoan)Untreated>99%Without treatment this disease is nearly invariably fatal due to its parasitic and extremely debilitating nature [8] [9]
Visceral leishmaniasis Parasitic (protozoan)Untreated>99% [10]
Naegleriasis Amoebic infectionUntreated≈98.5%From 1962 to 2022 there have been 157 recorded cases of the infection in United States, only 4 of those 157 individuals survived the disease. A combination of drugs have shown effectiveness in survivors. [11]
Glanders, septicemic BacterialUntreated95%The rate drops significantly to >50% with treatment. [12]
Smallpox Variola major – specifically the malignant (flat) or hemorrhagic typeViralUntreated≈95%The rate dropped significantly to 10% with effective treatments.
Eradicated.		 [7] : 28 
[13]
Granulomatous amoebic encephalitis Amoebic infectionNo cure [14] 90%150 cases worldwide, only < 10 survivors have been identified. [15] [16]
AIDS/HIV infection ViralUntreated90% [17] : 1 
Anthrax, pulmonary BacterialUnvaccinated and untreated> 85%Early treatments lower the CFR to 45% as seen in the 2001 AMERITHRAX letter attacks.
Monoclonal antibodies (Obilotoxaximab & Raxibacumab) could lower this further.		 [7] : 88 
Lujo virus Viral80%
B virus ViralUntreated≈80%Early treatment including aciclovir can improve prognosis. [18]
Aspergillosis, invasive pulmonary formFungalOpportunistic w/COPD, Tuberculosis and Immuno-
compromised		[50–90]% [19]
Smallpox, Variola major – in pregnant womenViralUnvaccinated> 65%Eradicated. [7] : 88 
Influenza A virus subtype H5N1 Viral≈53% [20]
Mucormycosis (Black fungus)Fungal[40–80]% [21]
Tularemia, pneumonicBacterialUntreated≤ 60% [7] : 78 
Ebola – specifically EBOV ViralUnvaccinated and untreated[25–90]%Prognosis improved by early supportive treatments as seen in the West African epidemic and the Kivu outbreak. [22] [23]
Marburg virus disease – all outbreaks combinedViralUntreated[23–90]%23% in 1967 when it was first identified and 90% in 2004-2005 when the worst outbreak of the disease occurred. Galidesivir has shown promise in treating Filoviridae [24] [25]
Cryptococcal meningitis FungalCo-infection with HIV[40–60]%6 month mortality is >=60% with fluconazole-based therapy and 40% with amphotericin-based therapy in research studies in low and middle income countries. [26]
Anthrax, gastrointestinal type BacterialUnvaccinated and untreated> 50% [7] : 27 
Tetanus, GeneralizedBacterialUnvaccinated and untreated50%CFR drops to [10–20]% with effective treatment. [27]
Tuberculosis, HIV Negative BacterialVaccinated43%Vaccines have been developed but have been frequently dismissed for having received controversial and improper testing on African populations. [28]
Plague, septicemic BacterialUnvaccinated and untreated[30–50]% [7] : 58 
Baylisascariasis Parasitic (helminthous)≈40%With occurrence of Neural Larva Migrans; early, aggressive treatment necessary for survival, but only 2 full recoveries from NLM ever documented [29]
Hantavirus infection Viral36% Ribavirin may be a drug for HPS and HFRS but its effectiveness remains unknown, still, spontaneous recovery is possible with supportive treatment.
Middle Eastern Respiratory Syndrome (MERS)Viral34% Galidesivir has shown promise in treating Coronaviridae [30]
Eastern equine encephalitis Viral≈33% [31]
Bubonic plague BacterialUnvaccinated and untreated[5–60]% [7] : 57 
Anthrax, gastrointestinal, oropharyngeal type Bacterial[10–50]% [7] : 27 
Smallpox, Variola majorViralUnvaccinated30% [7] : 88 
Varicella (chickenpox), in newbornsViralUntreated≈30%Where the mothers develop the disease between 5 days prior to, or 2 days after delivery. [17] : 110 
Dengue haemorrhagic fever (DHF) ViralUntreated26%Dengue haemorrhagic fever is also known as severe dengue. [32] [33]
Murray Valley encephalitis (MVE) ViralNo cure[15–30]%No specific treatment; usually involves supportive care. [34]
Hantavirus pulmonary syndrome (HPS)ViralUntreated≈21% Galidesivir has shown promise in treating Bunyavirales [35]
Tularemia, typhoidalBacterialUntreated[3–35]% [7] : 77 
Leptospirosis Bacterial<[5–30]% [17] : 352 
Meningococcal disease BacterialUnvaccinated and untreated[10–20]% [36]
Typhoid fever BacterialUnvaccinated and untreated[10–20]% [17] : 665 
Legionellosis Bacterial≈15% [17] : 665 
Severe acute respiratory syndrome (SARS) Viral11% Galidesivir has shown promise in treating Coronaviridae. [37]
Intestinal capillariasis Parasitic (helminthous)Untreated≈10% [38]
Visceral leishmaniasis Parasitic (protozoan)≈10% [39]
Botulism Bacterial toxinTreated< 10%Untreated foodborne botulism is thought to be ≈50% [40]
Diphtheria, respiratory BacterialUnvaccinated and untreated≈[5-10]% [41]
Yellow fever ViralUnvaccinated7.5% [42]
Pertussis (whooping cough), infants in developing countriesBacterialUnvaccinated≈3.7% [17] : 456 
Smallpox, Variola major ViralVaccinated3% [7] : 88 
Cholera, in AfricaBacterial≈[2–3]%With proper treatment, may be less than 1%, while without treatment may reach 50% [43] [44] [45] [46] [47]
1918 (Spanish) flu ViralTreated[2.5-9.7]%varies with population, up to 22% in Western Samoa [48] [49] [50]
Angiostrongyliasis Parasitic (helminthous)≈2.4%From Hawaiian cases. [51]
Measles (rubeola), in developing countriesViralUnvaccinated≈[1–3]%May reach [10–30]% in some localities. [17] : 431 
Brucellosis BacterialUntreated≤ 2% [17] : 87 
Hepatitis A, adults > 50 years oldViralUnvaccinated≈1.8% [17] : 278 
Coronavirus disease 2019 (COVID-19)ViralUnvaccinated &
Treated with unspecific treatments		0.5-1%Depends largely on the age group of the person. [52] [53]
Lassa fever ViralTreated≈1%15% in hospitalized patients; higher in some epidemics. [54]
Mumps encephalitis ViralUnvaccinated≈1% [17] : 431 
Pertussis (whooping cough), children in developing countriesBacterialUnvaccinated≈1%For children 1–4 years old. [17] : 456 
Smallpox, Variola minor ViralUnvaccinated1% [7] : 87–88 
Venezuelan Equine Encephalitis (VEE) Viral< 1% [7] : 97–98 
Anthrax, cutaneous Bacterial< 1% [7] : 27 
Seasonal Influenza, WorldwideViralLargely unvaccinated,
Treated		< 0.1–0.5%[ failed verification ]Depends largely on the age group of the people. [55]
Malaria Parasitic (protozoan)≈0.3% [56]
Hepatitis A ViralUnvaccinated[0.1–0.3]% [17] : 278 
Polio ViralWithout artificial breathing support≈0.1%, varies by age: 2-5% for children and up to 15-30% for adults0.5% of all infected become paralysed. Of those, about [10–20]% die. [57] [58]
Asian (1956–58) flu Viral≈0.1% [59]
Hong Kong (1968–69) flu Viral≈0.1% [59]
Influenza A, typical pandemics Viral< 0.1% [48]
Varicella (chickenpox), adultsViralUnvaccinated0.02% [17] : 110 
Hand, foot and mouth disease, children < 5 years oldViral0.01% [60]
Varicella (chickenpox), childrenViralUnvaccinated0.001% [17] : 110 

See also

Related Research Articles

<span class="mw-page-title-main">Lassa fever</span> Viral disease spread by a type of mouse

Lassa fever, also known as Lassa hemorrhagic fever, is a type of viral hemorrhagic fever caused by the Lassa virus. Many of those infected by the virus do not develop symptoms. When symptoms occur they typically include fever, weakness, headaches, vomiting, and muscle pains. Less commonly there may be bleeding from the mouth or gastrointestinal tract. The risk of death once infected is about one percent and frequently occurs within two weeks of the onset of symptoms. Of those who survive, about a quarter have hearing loss, which improves within three months in about half of these cases.

<span class="mw-page-title-main">Pandemic</span> Widespread, often global, epidemic of severe infectious disease

A pandemic is an epidemic of an infectious disease that has spread across a large region, for instance multiple continents or worldwide, affecting a substantial number of individuals. Widespread endemic diseases with a stable number of infected individuals such as recurrences of seasonal influenza are generally excluded as they occur simultaneously in large regions of the globe rather than being spread worldwide.

<span class="mw-page-title-main">Encephalitis</span> Inflammation of the brain

Encephalitis is inflammation of the brain. The severity can be variable with symptoms including reduction or alteration in consciousness, headache, fever, confusion, a stiff neck, and vomiting. Complications may include seizures, hallucinations, trouble speaking, memory problems, and problems with hearing.

<span class="mw-page-title-main">Measles</span> Viral disease affecting humans

Measles is a highly contagious, vaccine-preventable infectious disease caused by measles virus. Symptoms usually develop 10–12 days after exposure to an infected person and last 7–10 days. Initial symptoms typically include fever, often greater than 40 °C (104 °F), cough, runny nose, and inflamed eyes. Small white spots known as Koplik's spots may form inside the mouth two or three days after the start of symptoms. A red, flat rash which usually starts on the face and then spreads to the rest of the body typically begins three to five days after the start of symptoms. Common complications include diarrhea, middle ear infection (7%), and pneumonia (6%). These occur in part due to measles-induced immunosuppression. Less commonly seizures, blindness, or inflammation of the brain may occur. Other names include morbilli, rubeola, red measles, and English measles. Both rubella, also known as German measles, and roseola are different diseases caused by unrelated viruses.

<span class="mw-page-title-main">Epidemic</span> Rapid spread of disease affecting a large number of people in a short time

An epidemic is the rapid spread of disease to a large number of hosts in a given population within a short period of time. For example, in meningococcal infections, an attack rate in excess of 15 cases per 100,000 people for two consecutive weeks is considered an epidemic.

<span class="mw-page-title-main">Spanish flu</span> 1918–1920 global influenza pandemic caused by the H1N1 influenza A virus

The 1918–1920 flu pandemic, also known as the Great Influenza epidemic or by the common misnomer Spanish flu, was an exceptionally deadly global influenza pandemic caused by the H1N1 influenza A virus. The earliest documented case was March 1918 in the state of Kansas in the United States, with further cases recorded in France, Germany and the United Kingdom in April. Two years later, nearly a third of the global population, or an estimated 500 million people, had been infected in four successive waves. Estimates of deaths range from 17 million to 50 million, and possibly as high as 100 million, making it one of the deadliest pandemics in history.

<span class="mw-page-title-main">Mpox</span> Viral disease of humans and animals

Mpox is an infectious viral disease that can occur in humans and some other animals. Symptoms include a rash that forms blisters and then crusts over, fever, and swollen lymph nodes. The illness is usually mild and most of those infected will recover within a few weeks without treatment. The time from exposure to onset of symptoms ranges from five to twenty-one days and symptoms typically last from two to four weeks. Cases may be severe, especially in children, pregnant women or people with suppressed immune systems.

<span class="mw-page-title-main">Oseltamivir</span> Antiviral medication used against influenza A and influenza B

Oseltamivir, sold under the brand name Tamiflu, is an antiviral medication used to treat and prevent influenza A and influenza B, viruses that cause the flu. Many medical organizations recommend it in people who have complications or are at high risk of complications within 48 hours of first symptoms of infection. They recommend it to prevent infection in those at high risk, but not the general population. The Centers for Disease Control and Prevention (CDC) recommends that clinicians use their discretion to treat those at lower risk who present within 48 hours of first symptoms of infection. It is taken by mouth, either as a pill or liquid.

<span class="mw-page-title-main">Influenza vaccine</span> Vaccine against influenza

Influenza vaccines, colloquially known as flu shots, are vaccines that protect against infection by influenza viruses. New versions of the vaccines are developed twice a year, as the influenza virus rapidly changes. While their effectiveness varies from year to year, most provide modest to high protection against influenza. Vaccination against influenza began in the 1930s, with large-scale availability in the United States beginning in 1945.

<span class="mw-page-title-main">Swine influenza</span> Infection caused by influenza viruses endemic to pigs

Swine influenza is an infection caused by any of several types of swine influenza viruses. Swine influenza virus (SIV) or swine-origin influenza virus (S-OIV) refers to any strain of the influenza family of viruses that is endemic in pigs. As of 2009, identified SIV strains include influenza C and the subtypes of influenza A known as H1N1, H1N2, H2N1, H3N1, H3N2, and H2N3.

<i>Nipah virus</i> Species of virus

Nipah virus is a bat-borne, zoonotic virus that causes Nipah virus infection in humans and other animals, a disease with a very high mortality rate (40-75%). Numerous disease outbreaks caused by Nipah virus have occurred in South East Africa and Southeast Asia. Nipah virus belongs to the genus Henipavirus along with the Hendra virus, which has also caused disease outbreaks.

<span class="mw-page-title-main">Tick-borne encephalitis</span> Medical condition

Tick-borne encephalitis (TBE) is a viral infectious disease involving the central nervous system. The disease most often manifests as meningitis, encephalitis or meningoencephalitis. Myelitis and spinal paralysis also occurs. In about one third of cases sequelae, predominantly cognitive dysfunction, persist for a year or more.

<span class="mw-page-title-main">Flu season</span> Recurring periods of influenza

Flu season is an annually recurring time period characterized by the prevalence of an outbreak of influenza (flu). The season occurs during the cold half of the year in each hemisphere. It takes approximately two days to show symptoms. Influenza activity can sometimes be predicted and even tracked geographically. While the beginning of major flu activity in each season varies by location, in any specific location these minor epidemics usually take about three weeks to reach its pinnacle, and another three weeks to significantly diminish.

<span class="mw-page-title-main">Influenza pandemic</span> Pandemic involving influenza

An influenza pandemic is an epidemic of an influenza virus that spreads across a large region and infects a large proportion of the population. There have been six major influenza epidemics in the last 140 years, with the 1918 flu pandemic being the most severe; this is estimated to have been responsible for the deaths of 50–100 million people. The 2009 swine flu pandemic resulted in under 300,000 deaths and is considered relatively mild. These pandemics occur irregularly.

In epidemiology, case fatality rate (CFR) – or sometimes more accurately case-fatality risk – is the proportion of people who have been diagnosed with a certain disease and end up dying of it. Unlike a disease's mortality rate, the CFR does not take into account the time period between disease onset and death. A CFR is generally expressed as a percentage. It is a measure of disease lethality, and thus may change with different treatments. CFRs are most often used for with discrete, limited-time courses, such as acute infections.

<span class="mw-page-title-main">B virus</span> Species of virus

B-virus, Herpesvirus simiae, or Herpes virus B is the Simplexvirus infecting macaque monkeys. B virus is very similar to HSV-1, and as such, this neurotropic virus is not found in the blood.

<span class="mw-page-title-main">2009 swine flu pandemic</span> 2009–2010 pandemic of swine influenza caused by H1N1 influenza virus

The 2009 swine flu pandemic, caused by the H1N1/swine flu/influenza virus and declared by the World Health Organization (WHO) from June 2009 to August 2010, was the third recent flu pandemic involving the H1N1 virus. The first identified human case was in La Gloria, Mexico, a rural town in Veracruz. The virus appeared to be a new strain of H1N1 that resulted from a previous triple reassortment of bird, swine, and human flu viruses which further combined with a Eurasian pig flu virus, leading to the term "swine flu".

<span class="mw-page-title-main">Nipah virus infection</span> Disease caused by Nipah virus

A Nipah virus infection is a viral infection caused by the Nipah virus. Symptoms from infection vary from none to fever, cough, headache, shortness of breath, and confusion. This may worsen into a coma over a day or two, and 50 to 75% of those infected die. Complications can include inflammation of the brain and seizures following recovery.

References

  1. ↑ "Creutzfeldt-Jakob Disease (CJD): Symptoms & Treatment". Cleveland Clinic. Retrieved 2024-03-05.
  2. ↑ Weiss, Cynthia (27 June 2021). "Sharing Mayo Clinic: Back from the brink and overcoming a rare neurologic disorder". Mayo Clinic News Network. Retrieved 8 January 2023.
  3. ↑ Krance SH, Luke R, Shenouda M, Israwi AR, Colpitts SJ, Darwish L, et al. (January 2020). "Cellular models for discovering prion disease therapeutics: Progress and challenges". Journal of Neurochemistry. 153 (2): 150–172. doi: 10.1111/jnc.14956 . PMID   31943194.
  4. ↑ "Deadliest diseases ranked?". CBS news. 2 April 2020. Archived from the original on 2021-03-12. Retrieved 2021-03-18.
  5. ↑ "Is Rabies Really 100% Fatal? | Viruses101 | Learn Science at Scitable". www.nature.com. Retrieved 2023-08-17.
  6. ↑ Jackson, AC (November 2016). "Human Rabies: a 2016 Update". Current infectious disease reports. 18 (11): 38. doi:10.1007/s11908-016-0540-y. PMID   27730539.
  7. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 USAMRIID (2011). USAMRIID's Medical Management of Biological Casualties Handbook (PDF) (7th ed.). U.S. Government Printing Office. ISBN   9780160900150. Archived from the original (PDF) on 2015-02-09. Retrieved 2012-08-01.
  8. ↑ "CDC - African Trypanosomiasis - General Information - East African Trypanosomiasis FAQs". www.cdc.gov. 2019-04-22. Retrieved 2023-08-17.
  9. ↑ "African Sleeping Sickness". Seattle Biomed. 2014. Archived from the original on 2014-06-07. Retrieved 2014-06-04.
  10. ↑ World Health Organization, (2013) "Health Topics: Leishmaniasis." Archived 2016-11-22 at the Wayback Machine
  11. ↑ "General Information | Naegleria fowleri". CDC. 2023-05-03. Retrieved 2023-07-11.
  12. ↑ "Department of Agriculture | Glanders". www.nj.gov. Retrieved 2023-09-06.
  13. ↑ "Smallpox Disease and Its Clinical Management" (PDF). From the training course titled "Smallpox: Disease, Prevention, and Intervention" (www.bt.cdc.gov/agent/smallpox/training/overview). Archived from the original (PDF) on 2016-05-10. Retrieved 2007-12-26.
  14. ↑ Baig AM (December 2014). "Granulomatous amoebic encephalitis: ghost response of an immunocompromised host?". Journal of Medical Microbiology. 63 (Pt 12): 1763–1766. doi: 10.1099/jmm.0.081315-0 . PMID   25239626. S2CID   28069984.
  15. ↑ Umar, Imram; Kolyvas, George; Visvesvara, Govinda S.; Bilbao, Juan; Guiot, Marie-Christine; Duplisea, Kevin; Qvarnstrom, Yvonne; Webster, Duncan (3 October 2012). "Treatment of Granulomatous Amoebic Encephalitis with Voriconazole and Miltefosine in an Immunocompetent Soldier". The American Journal of Tropical Medicine and Hygiene. 87 (4): 715–718. doi:10.4269/ajtmh.2012.12-0100. PMC   3516325 . PMID   22869634.
  16. ↑ Keane, Niamh A.; Lane, Louise Marie; Canniff, Emma; Hare, Daniel; Doran, Simon; Wallace, Eugene; Hutchinson, Siobhan; Healy, Marie-Louise; Hennessy, Brian; Meaney, Jim; Chiodini, Peter; O’Connell, Brian; Beausang, Alan; Vandenberghe, Elisabeth (30 June 2020). "A Surviving Case of Acanthamoeba Granulomatous Amebic Encephalitis in a Hematopoietic Stem Cell Transplant Recipient". American Journal of Case Reports. 21: e923219. doi:10.12659/AJCR.923219. PMC   7347033 . PMID   32603318.
  17. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 Heymann DL, ed. (2008). Control of Communicable Diseases Manual (19th ed.). Washington, D.C.: American Public Health Association. ISBN   978-0-87553-189-2.
  18. ↑ Liu D (2014-04-08). Manual of Security Sensitive Microbes and Toxins. CRC Press. p. 33. ISBN   978-1-4665-5396-5. Archived from the original on 2021-09-26. Retrieved 2020-05-15.
  19. ↑ Kousha, M.; Tadi, R.; Soubani, A. O. (31 August 2011). "Pulmonary aspergillosis: a clinical review". European Respiratory Review. 20 (121): 156–174. doi: 10.1183/09059180.00001011 . PMC   9584108 . PMID   21881144.
  20. ↑ "Cumulative number of confirmed human cases for avian influenza A(H5N1) reported to WHO, 2003-2021". World Health Organization. Retrieved January 3, 2023.
  21. ↑ "Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium" (PDF). European Confederation of Medical Mycology. 4 November 2019. Archived (PDF) from the original on 2 March 2021. Retrieved 31 May 2021.
  22. ↑ "Ebola virus disease Fact sheet N°103". World Health Organization. March 2014. Archived from the original on 14 December 2014. Retrieved 12 April 2014.
  23. ↑ Fauquet CM, Mayo MA, Maniloff J, Desselberger U, Ball LA, eds. (2005). Virus taxonomy: classification and nomenclature of viruses. Oxford: Elsevier/Academic Press. p. 648. ISBN   978-0-08057-548-3. Archived from the original on 2020-08-01. Retrieved 2017-09-03.
  24. ↑ Jacob, H.; Solcher, H. (1968). "Über eine durch grüne Meerkatzen (Cercopithecus aethiops) übertragene, zu Gliaknötchenencephalitis führende Infektionskrankheit ('Marburger Krankheit')" [An infectious disease transmitted by Cercopithecus aethiops ('marbury disease') with glial nodule encephalitis]. Acta Neuropathologica (in German). 11 (1): 29–44. doi:10.1007/BF00692793. PMID   5748997.
  25. ↑ Hovette, P (2005). "Epidémie de fièvre hémorragique à virus marburg en Angola" [Epidemic of Marburg hemorrhagic fever in Angola]. Médecine Tropicale (in French). 65 (2): 127–8. PMID   16038348.
  26. ↑ Rajasingham R, Rolfes MA, Birkenkamp KE, Meya DB, Boulware DR (25 September 2012). "Cryptococcal meningitis treatment strategies in resource-limited settings: a cost-effectiveness analysis". PLOS Medicine. 9 (9): e1001316. doi: 10.1371/journal.pmed.1001316 . PMC   3463510 . PMID   23055838.
  27. ↑ Hinfey, Patrick B (Jan 18, 2019). "What is the mortality rate for tetanus (lockjaw)?". Medscape. Archived from the original on August 14, 2019. Retrieved August 14, 2019.
  28. ↑ Tiemersma EW, van der Werf MJ, Borgdorff MW, Williams BG, Nagelkerke NJ (April 2011). "Natural history of tuberculosis: duration and fatality of untreated pulmonary tuberculosis in HIV negative patients: a systematic review". PLOS ONE. 6 (4): e17601. Bibcode:2011PLoSO...617601T. doi: 10.1371/journal.pone.0017601 . PMC   3070694 . PMID   21483732.
  29. ↑ Kazacos KR (2016). Abbott RC, Van Riper C (eds.). "Baylisascaris Larva Migrans". Circular 1412. Circular: 136. doi: 10.3133/cir1412 . Archived from the original on 2018-03-22. Retrieved 2018-03-21.
  30. ↑ "MERS situation update". WHO Regional Office for the Eastern Mediterranean . April 2021. Archived from the original on 29 July 2019. Retrieved 31 May 2021.
  31. ↑ "Eastern Equine Encephalitis | Eastern Equine Encephalitis | CDC". www.cdc.gov. 2023-06-14. Retrieved 2023-09-06.
  32. ↑ "Dengue and severe dengue". World Health Organization. Fact sheet N°117. March 2014. Archived from the original on 2016-09-02. Retrieved 2014-08-08.
  33. ↑ Ranjit S, Kissoon N (January 2011). "Dengue hemorrhagic fever and shock syndromes". Pediatric Critical Care Medicine. 12 (1): 90–100. doi:10.1097/PCC.0b013e3181e911a7. PMID   20639791. S2CID   10135251.
  34. ↑ Niven, D. J.; Afra, K.; Iftinca, M.; Tellier, R.; Fonseca, K.; Kramer, A.; Safronetz, D.; Holloway, K.; Drebot, M.; Johnson, A. S. (2017). "Fatal Infection with Murray Valley Encephalitis Virus Imported from Australia to Canada, 2011". Emerging Infectious Diseases. 23 (2): 280–283. doi:10.3201/eid2302.161161. PMC   5324805 . PMID   28098530.
  35. ↑ Alonso DO, Iglesias A, Coelho R, Periolo N, Bruno A, Córdoba MT, et al. (July 2019). "Epidemiological description, case-fatality rate, and trends of Hantavirus Pulmonary Syndrome: 9 years of surveillance in Argentina". Journal of Medical Virology. 91 (7): 1173–1181. doi:10.1002/jmv.25446. hdl: 11336/132489 . PMID   30840775. S2CID   73484756.
  36. ↑ Ghuneim, Nedal; Dheir, Majdi; Issawi, Fouad (December 2013). "Incidence and case-fatality rate of meningococcal meningitis and meningococcal septicaemia in the Gaza Strip, occupied Palestinian territory, during 2011". The Lancet. 382: S12. doi: 10.1016/S0140-6736(13)62584-2 . S2CID   54396333.
  37. ↑ "Consensus document on the epidemiology of severe acute respiratory syndrome (SARS)" (PDF). Department of Communicable Disease Surveillance and Response. World Health Organization. 2003. p. 10. Archived (PDF) from the original on 2020-01-29. Retrieved 2020-10-05.
  38. ↑ Bernstein D. "Intestinal Parasite Infections From Roundworms – Description, Diagnosis, Treatment". Fungus Focus. Archived from the original on 2016-03-04. Retrieved 2013-03-29.
  39. ↑ "Initiative for Vaccine Research (IVR): Parasitic Diseases – Leishmaniasis". World Health Organization. 2013. Archived from the original on March 22, 2006.
  40. ↑ Shapiro, Roger L. (1998-08-01). "Botulism in the United States: A Clinical and Epidemiologic Review". Annals of Internal Medicine. 129 (3): 221–228. doi:10.7326/0003-4819-129-3-199808010-00011. ISSN   0003-4819. PMID   9696731. S2CID   23705912.
  41. ↑ Centers for Disease Control and Prevention, (7 February 2011) "Diphtheria." Archived 2016-04-12 at the Wayback Machine
  42. ↑ "Yellow fever". Fact sheets. World Health Organization. 7 May 2019. Archived from the original on 19 February 2014. Retrieved 5 October 2020.
  43. ↑ Nsubuga, Fred; Garang, Stephen Chol; Tut, Mathew; Oguttu, David; Lubajo, Robert; Lodiongo, Dennis; Lasuba, Michael; Mpairwe, Allan (3 January 2019). "Epidemiological description of a protracted cholera outbreak in Tonj East and Tonj North counties, former Warrap State, South Sudan, May-Oct 2017". BMC Infectious Diseases. 19 (1): 4. doi: 10.1186/s12879-018-3640-5 . PMC   6318988 . PMID   30606126.
  44. ↑ Msyamboza, Kelias Phiri; Kagoli, Mathew; M'bang'ombe, Maurice; Chipeta, Sikhona; Masuku, Humphrey Dzanjo (11 June 2014). "Cholera outbreaks in Malawi in 1998-2012: social and cultural challenges in prevention and control". The Journal of Infection in Developing Countries. 8 (6): 720–726. doi: 10.3855/jidc.3506 . PMID   24916870.
  45. ↑ Noora, Charles Lwanga; Issah, Kofi; Kenu, Ernest; Bachan, Emmanuel George; Nuoh, Robert Domo; Nyarko, Kofi Mensah; Appiah, Paulina; Letsa, Timothy (10 August 2017). "Large cholera outbreak in Brong Ahafo Region, Ghana". BMC Research Notes. 10 (1): 389. doi: 10.1186/s13104-017-2728-0 . PMC   5553860 . PMID   28797285.
  46. ↑ Alkassoum, S I; Djibo, I; Amadou, H; Bohari, A; Issoufou, H; Aka, J; Mamadou, S (May 2019). "The global burden of cholera outbreaks in Niger: an analysis of the national surveillance data, 2003–2015". Transactions of the Royal Society of Tropical Medicine and Hygiene. 113 (5): 273–280. doi:10.1093/trstmh/try145. PMID   30715523.
  47. ↑ Clemens, John D; Nair, G Balakrish; Ahmed, Tahmeed; Qadri, Firdausi; Holmgren, Jan (September 2017). "Cholera". The Lancet. 390 (10101): 1539–1549. doi:10.1016/S0140-6736(17)30559-7. PMID   28302312. S2CID   208787765.
  48. 1 2 Taubenberger, Jeffery K.; Morens, David M. (January 2006). "1918 Influenza: the Mother of All Pandemics". Emerging Infectious Diseases. 12 (1): 15–22. doi:10.3201/eid1201.050979. PMC   3291398 . PMID   16494711.
  49. ↑ Hong NH (2015). "Epidemic Analysis of 1918 Influenza in China – Research on Huolu County in Zhili Province". Historical Research in Auhui.
  50. ↑ Kohn GC (2007). Encyclopedia of plague and pestilence: from ancient times to the present (3rd ed.). Infobase Publishing. p. 363. ISBN   978-0-8160-6935-4. Archived from the original on 1 January 2016. Retrieved 29 October 2015– via Google Books.
  51. ↑ Johnston DI, Dixon MC, Elm JL, Calimlim PS, Sciulli RH, Park SY (September 2019). "Review of Cases of Angiostrongyliasis in Hawaii, 2007-2017". The American Journal of Tropical Medicine and Hygiene. 101 (3): 608–616. doi:10.4269/ajtmh.19-0280. PMC   6726938 . PMID   31287041.
  52. ↑ "Estimating mortality from COVID-19". www.who.int. Retrieved 2023-09-07.
  53. ↑ Ritchie, Hannah; Mathieu, Edouard; Rodés-Guirao, Lucas; Appel, Cameron; Giattino, Charlie; Ortiz-Ospina, Esteban; Hasell, Joe; MacDonald, Bobbie; Beltekian, Diana; Roser, Max (August 23, 2021). "Mortality Risk of COVID-19". Our World in Data. Archived from the original on August 24, 2021. Retrieved August 23, 2021.
  54. ↑ "Lassa fever". World Health Organization . 31 July 2017. Archived from the original on 5 August 2012. Retrieved 31 May 2021.
  55. ↑ Iuliano, A Danielle; Roguski, Katherine M; Chang, Howard H; Muscatello, David J; Palekar, Rakhee; Tempia, Stefano; Cohen, Cheryl; Gran, Jon Michael; Schanzer, Dena; Cowling, Benjamin J; Wu, Peng (March 2018). "Estimates of global seasonal influenza-associated respiratory mortality: a modelling study". The Lancet. 391 (10127): 1285–1300. doi:10.1016/S0140-6736(17)33293-2. PMC   5935243 . PMID   29248255.
  56. ↑ "Malaria". WHO . WHO. December 2014. Archived from the original on 3 September 2014. Retrieved 14 Jan 2015.
  57. ↑ "Poliomyelitis". WHO . WHO. 22 July 2019. Archived from the original on 17 October 2019. Retrieved 12 May 2020.
  58. ↑ Hamborsky J, Kroger A, Wolfe C, eds. (2015), "Poliomyelitis", Epidemiology and Prevention of Vaccine-Preventable Diseases (The Pink Book) (13th ed.), Washington DC: Public Health Foundation, (chap. 18), archived from the original on 30 December 2016.
  59. 1 2 Li, F C K; Choi, B C K; Sly, T; Pak, A W P (1 June 2008). "Finding the real case-fatality rate of H5N1 avian influenza". Journal of Epidemiology & Community Health. 62 (6): 555–559. doi:10.1136/jech.2007.064030. PMID   18477756. S2CID   34200426.
  60. ↑ Wang X, Wu X, Jia L, Li X, Li J, Li S, Qian H, Wang Q (August 2014). "Estimating the number of hand, foot and mouth disease amongst children aged under-five in Beijing during 2012, based on a telephone survey of healthcare seeking behavior". BMC Infectious Diseases. 14: 437. doi: 10.1186/1471-2334-14-437 . PMC   4149051 . PMID   25117760.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.